FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Rifampin

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot #A200170, exp. date December 2023
Where it was soldProduct was distributed nationwide.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byLupin Pharmaceuticals, Inc.
Brand nameRIFAMPIN
Generic nameRIFAMPIN
Active ingredient(s)RIFAMPIN
Distributed by / forLupin Pharmaceuticals, Inc., Baltimore, MD, 21202
NDC68180-658-06
Show the full FDA record
Full product labelRifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202 NDC: 68180-658-06
Recalling firmLupin Pharmaceuticals Inc.
DistributionProduct was distributed nationwide.
Quantity7,872/30 count bottles
Recall initiated2022-07-28
Report date2022-08-24
Recall completed2023-10-05
Recall numberD-1343-2022
ClassificationClass II
FDA statusTerminated
Origin on fileBaltimore MD United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.